top of page

Search Results

Results found for "custom ligand development"

  • 📰 GPCR Weekly News, July 31 to August 6, 2023

    Randy Hall's study: GPR37L1's role in shaping cortical astrocytes during development Dr. Drugs, and more Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors Development GHS-R1a/D2R heterodimers GPR37L1 controls maturation and organization of cortical astrocytes during development Closes $115 Million Loan Facility with Hercules Capital Gene-to-structure and Europe give Proteros customers

  • Innovative Data-Driven Solutions: The pHSense Revolution

    That’s the promise of pHSense, a groundbreaking reagent developed by Eric Trinquet and his team at Revvity Mini Timeline: pHSense Development Early 2020s: Rare-earth probe synthesis begins Collaborative screening User feedback will guide the development of future tags and variants.

  • How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs

    Originally developed as ultra-bright lanthanide probes, the team realized they could tune these molecules Mini Timeline 🎯 Early 2000s: Trinquet leads IP1 & Tag-lite development 🧪 Mid-2010s: Rare-earth scaffold Product development isn’t just about science.

  • Unlock the Hidden Complexity Behind GPCRs—From Terry Kenakin’s Vault

    biased signaling, and allosteric modulation, this session lays bare the science that’s reshaping how we develop

  • Ever Wondered How Drugs Are Discovered?

    the language, logic, and big-picture view that underpins all future learning in pharmacology and drug development

  • 📰 GPCR Weekly News, June 10 to 16, 2024

    Stay informed with the most recent developments in GPCR research and industry news. hiPSC-cardiomyocytes to GPCR and ion channel targeting compounds: A microphysiological system for cardiac drug development Exscientia Appoints New Leaders to Strengthen the Impact of Integrated Technologies and Focus Clinical Development

  • A Note from Yamina: Building the Next Chapter of Dr. GPCR

    a place for teams to get tailored scientific and strategic guidance that helps bridge discovery and development Our access program for researchers in developing countries  continues as well: eligible scientists can GPCR University course reserves five complimentary seats for students from developing countries — no

  • Job Opportunity Spotlight #1: Principal Scientist, In Vitro Pharmacology

    Someone with strong assay development skills as well as strong data analysis and interpretation skills s comradery and open exchange in our team and I strive to provide learning opportunities for career development

  • Harnessing Deep Mutational Scanning for Enhanced Drug Discovery

    Predicting and Overcoming Drug Resistance A significant challenge in drug development, particularly in designed to target multiple sites or pathways simultaneously, reducing the likelihood of resistance development This can guide the development of more personalised therapies tailored to the genetic makeup of individual Another promising development is the application of DMS to a wider array of biological systems, including

  • The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think

    :  Explore a selection of high-level job openings in high-throughput screening, research, biologics development compounds that might be missed by traditional screening methods, gaining a first-mover advantage in developing  Gain a deeper understanding of the pharmacological underpinnings of opioid overdose, informing the development

  • From DNA day to GPCR genomics

    This breakthrough also paved the way for the development of genomics, a field of study that examines genomics and GPCR research sparked a new era of a comprehensive understanding of GPCR biology, the development bioinformatics analysis, have facilitated drug discovery and design targeting GPCRs, leading to the development pharmacology, bioinformatics, and clinical research has opened new avenues for exploring GPCR biology, developing

  • Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...

    , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development today announced that its collaboration agreement with Indivior PLC (LON: INDV) for discovering and developing The reserved indications, where Addex retains exclusive rights to develop its own independent GABAB PAM program, have also been expanded to include chronic cough, in addition to the rights to develop certain

  • What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024

    Join us for this week’s update, where you’ll find all the latest breakthroughs and exciting developments GPCR News from November 4th to 10th, 2024 Industry News Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments Update GPCR Events, Meetings, and Webinars NEW November 18 - 20, 2024 | 7th CB1 & CB2 Targeting Drug Development

  • 📰 GPCR Weekly News, April 17 to 23, 2023

    GPCR Binders, Drugs, and more Development of a 5-HT7 receptor antibody for the rat: the good, the bad Industry News Data Presented at AACR 2023 Highlights Exscientia’s Clinical and Preclinical Development Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. Antibody Engineering Scientist—Immuno-Oncology Convergent Research - Senior Scientist, Cell-Based Assay Development

  • Focusing on the role of secretin/adhesion (Class B) G protein-coupled receptors in placental...

    October 2022 Focusing on the role of secretin/adhesion (Class B) G protein-coupled receptors in placental development Obesity, immunological diseases and endocrine metabolic diseases are high-risk factors for the development system function and the drug target exploration, we summarize the role of these receptors in placental development

  • 📰 GPCR Weekly News, April 1 to 7, 2024

    We're excited to share our coverage of the latest developments in GPCRs for this week. Hoare's workshop for individuals who live and work in developing countries. We define a developing country based on World Bank Classifications for its 2024 fiscal year. Dr.

  • Single-molecule counting applied to the study of GPCR oligomerization

    proteins that participate in many vital physiological functions making them a popular target for drug development Here, we review recent developments in single-molecule counting with a focus on photobleaching step counting

  • Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology

    Explicyte grants Domain Therapeutics exclusivity on data related to GPCR implicated in immunoresistance, to develop March 10, 2022 – Domain Therapeutics, a biopharmaceutical company specializing in the discovery and development companies will combine their expertise to identify GPCR targets and associated biomarkers to discover and develop

  • 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024

    Exclusive Deal for Scientists Residing and Working in Developing Nations If you live and work  in a developing 2 -3, 2024 Come and join top scientists in exploring the latest breakthroughs in GPCR-targeted drug development

  • Integrative model of the FSH receptor reveals the structural role of the flexible hinge region

    FSHR is involved in reproductive processes such as gonadal development and maturation. The models are expected to allow for testable hypotheses about signal transduction and drug development

  • When Pain Becomes a Catalyst: How Personal Experience Redefined One Scientist’s Mission

    His interest in model development, in capturing the lived human experience through preclinical systems

  • High hedgehog signaling is transduced by a multikinase-dependent switch controlling the...

    October 2022 High hedgehog signaling is transduced by a multikinase-dependent switch controlling the apico-basal distribution of the GPCR smoothened "The oncogenic G-protein-coupled receptor (GPCR) Smoothened (SMO) is a key transducer of the hedgehog (HH) morphogen, which plays an essential role in the patterning of epithelial structures. Here, we examine how HH controls SMO subcellular localization and activity in a polarized epithelium using the Drosophila wing imaginal disc as a model. We provide evidence that HH promotes the stabilization of SMO by switching its fate after endocytosis toward recycling. This effect involves the sequential and additive action of protein kinase A, casein kinase I, and the Fused (FU) kinase. Moreover, in the presence of very high levels of HH, the second effect of FU leads to the local enrichment of SMO in the most basal domain of the cell membrane. Together, these results link the morphogenetic effects of HH to the apico-basal distribution of SMO and provide a novel mechanism for the regulation of a GPCR." Read more at the source #DrGPCR #GPCR #IndustryNews

  • Domain Therapeutics Raises $42m Series A Financing

    May 2022 "Published: May 10, 2022 To accelerate clinical development of its best-in-class and first-in-class France & MONTREAL- Domain Therapeutics, a biopharmaceutical company specializing in the research and development

  • TRPM3 in the eye and in the nervous system - from new findings to novel mechanisms

    TRPM3 expression patterns differ between species and change during development. The aim of this review is to highlight recent results and developments with particular focus on findings

  • In vivo detection of GPCR-dependent signaling using fiber photometry and FRET-based biosensors

    biosensors are based on the principle of Förster resonance energy transfer (FRET), and we have recently developed neuroscience research, ranging from the study of neural circuits and behavior, to preclinical drug development

  • ADGRL3 genomic variation implicated in neurogenesis and ADHD links functional effects to the...

    Adhesion G Protein-Coupled Receptor L3 (ADGRL3) gene are associated with increased susceptibility to developing these in silico predictions of the ADGRL3-GIP interaction and dissect the complexity underlying the development

  • Pharmacological Properties and Function of PxOctβ3 Octopamine Receptor in Plutella xylostella (L.)

    cruciferous vegetables, and insights into regulation of its physiological processes contribute towards the development the Octβ3 protein family, and an analysis using quantitative PCR showed that it was expressed at all developmental The injection of double-stranded RNA in an RNA interference assay indicated that PxOctβ3 regulates development

  • GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation

    inflammatory stimuli such as lipopolysaccharide (LPS) and TNFα suggests that it may play a role in the development Consistently, GPR84-/- mice are resistant to the development of colitis induced by DSS.

  • Serotonin Receptor 5-HT2A Regulates TrkB Receptor Function in Heteroreceptor Complexes

    An expression analysis revealed strong developmental regulation of 5-HT2A and TrkB expressions in the demonstrating that the balance between TrkB and 5-HT2A may shift in certain brain regions during postnatal development and TrkB is a molecular mechanism for the brain-region-specific modulation of TrkB functions during development

  • Ermium Therapeutics has constituted its SAB

    Advisory Board comprising international leaders in GPCRs pharmacology, immunology, drug discovery and development

bottom of page